The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Thoas Fioretos

Thoas Fioretos

Research team manager

Thoas Fioretos

Expression of NUP98/TOP1, but not of TOP1/NUP98, in a treatment-related myelodysplastic syndrome with t(10;20;11)(q24;q11;p15).

Author

  • Ioannis Panagopoulos
  • Thoas Fioretos
  • Margareth Isaksson
  • Gun Larsson
  • Rolf Billström
  • Felix Mitelman
  • Bertil Johansson

Summary, in English

The t(11;20)(p15;q11) is a rare but recurrent translocation that so far has been described in only four acute myeloid leukemias (AMLs), two treatment-related myelodysplastic syndromes (t-MDSs), and one case of polycythemia vera. Recently, the t(11;20) was shown to result in a fusion of the NUP98 and TOP1 genes, with expression of the NUP98/TOP1 chimera encoded by the der(11)t(11;20), but not of the reciprocal TOP1/NUP98 on the der(20)t(11;20). The genomic breakpoints were subsequently mapped to introns 13 and 7 of NUP98 and TOP1, respectively. We present here a t-MDS with a three-way variant translocation, t(10;20;11)(q24;q11;p15), that generates a der(11)t(11;20) but not a der(20)t(11;20), strongly suggesting that the der(11) harbors the critical genetic rearrangement. Reverse transcriptase-polymerase chain reaction (RT-PCR) revealed a NUP98/TOP1 fusion in which exon 13 of NUP98 was fused in-frame with exon 8 of TOP1. Extra long (XL) genomic PCR and subsequent sequence analyses showed that the breakpoint in NUP98 occurred at nucleotide (nt) 3461 of intron 13, close to a MER (medium reiteration frequency interspersed repetitive element) repeat, and that the breakpoint in TOP1 was at nt 1436 of intron 7, downstream of a MIR (mammalian-wide interspersed repeats) repetitive element. Genomic XL PCR did not amplify the reciprocal TOP1/NUP98, nor was this chimera expressed, as expected from the cytogenetic finding. The present results provide further support for the involvement of the NUP98/TOP1 transcript, but not of the reciprocal one, in the development of MDS/AML. Furthermore, the three cases genomically characterized to date have all been treatment-related and have all harbored breakpoints in intron 13 of NUP98 and intron 7 of TOP1, suggesting that these introns are susceptible to chemotherapy-induced breakage.

Department/s

  • Division of Clinical Genetics

Publishing year

2002

Language

English

Pages

249-254

Publication/Series

Genes, Chromosomes and Cancer

Volume

34

Issue

2

Document type

Journal article

Publisher

John Wiley & Sons Inc.

Topic

  • Medical Genetics

Keywords

  • Chromosomes
  • Human
  • Pair 20 : genetics
  • DNA Topoisomerases
  • Type I : biosynthesis
  • Type I : genetics
  • Female
  • Middle Age
  • Molecular Sequence Data
  • Myelodysplastic Syndromes : chemically induced
  • Myelodysplastic Syndromes : genetics
  • Nuclear Pore Complex Proteins : biosynthesis
  • Neoplasm Proteins : genetics
  • Nuclear Pore Complex Proteins : genetics
  • Support
  • Non-U.S. Gov't
  • Translocation (Genetics) : genetics
  • Pair 11 : genetics
  • Pair 10 : genetics
  • Human : genetics
  • Case Report
  • Base Sequence : genetics
  • Amino Acid Sequence : genetics

Status

Published

ISBN/ISSN/Other

  • ISSN: 1045-2257